PDCD1 and neoplasm: Tumor cells can induce tumor immune escape via the COX-2-PGE2 pathway (Jin et al., 2023), and the combination of celecoxib with anti-PD-1 monoclonal antibodies is faster than anti-PD-1 alone to induce tumor eradication (Zelenay et al., 2015).